CRH vs JAZZ · P/E 20, rev $18.15B vs P/E 1988, rev $2.28B
CRH PLC ADR (CRH) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
CRH PLC ADR (CRH) is a building materials company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CRH revenue for 2026-06-30 was $18.15B. Net income was $1.31B. CRH currently screens at market cap $63.62B and trailing P/E 20.1.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CRH currently screens at market cap $63.62B and trailing P/E 20.1. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CRH and JAZZ stock pages for the full models.
Not investment advice.